{
    "answer": "For the immunology segment, Cosentyx net sales for full year 2024, reported on a basis, were USD 2,044 million, and constant currency on a basis, were USD 1,996 million. A year-over-year comparison of 2023 figures to 2024 suggests that reported sales increased by 15% (from USD 1,807 million in Q4 2023 to USD 2,044 million in full year 2024), while constant currency sales also grew by 15% (from USD 1,794 million in Q4 2023 to USD 1,996 million in full year 2024).",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 5,
    "search count": 3,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        864,
        2284,
        3707,
        5331,
        5821
    ]
}